Abstract: Retinoic X receptor alpha (RXRA), a member of nuclear receptor superfamily, plays a key role in development, metabolism, glucose homeostasis, and intestinal cholesterol balance. The aim of this study was to examine an association of RXR alpha introne 5 A(39526)AA polymorphism and ABO blood groups with chronic heart failure (CHF) in the Czech population. A total of 238 patients with chronic heart failure and a control group of 246 subjects were included in the study. The RXR alpha gene polymorphism and ABO blood groups were detected by PCR and RFLP methods. Significant differences in distributions of RXRA A(39526)AA alleles and genotypes between CHF patients and controls were observed (P g =0.03, P a =0.02). The RXRA gene polymorphism differences of within blood group A between CHF patients and controls were highly significant in genotype distributions (P g =0.002) and in allele frequency comparisons (P a =0.0001). The prevalence of AA allele in CHF patients with A blood group was four-fold lower than in controls with the same blood group (OR=0.24; P corr =0.0001). A highly significant association of RXRA introne single-nucleotide insertion polymorphism and A blood group in chronic heart failure was observed. Our results suggest close linkage between RXRA A(39526)AA polymorphism and ABO blood groups.
Introduction
Since the beginning of the 20 th century, phenotypic effects and later molecular genetic basis of human ABO histoblood groups have been wildly discussed. Regarding to cardiovascular diseases, most of the papers observed higher predominance of A blood group and a deficit of O blood group with respect to coronary heart disease [1] [2] [3] , angina pectoris [4] [5] [6] , hypertension [7] , myocardial infarction [4, 8, 9] , and tromboembolic diseases [10, 11] . Phenotypic heterogeneity of ABO blood group system is due to structural difference of the glycosyltransferase gene that is located on chromosome 9q34 [12] . This gene controls the synthesis of glycosyltransferases that transfer specific sugar residues to the substrate H and convert it to antigen A and B. Blood group O results from an absence of glycosyltransferase A activity caused by a single-base deletion of guanine on position 258 and a frameshift mutation [13] . The B allele differs from the A allele by at least seven mutations; four of them lead to amino acid changes that may be responsible for the specificity of A and B transferase [14] . The retinoid X receptor alpha (RXR-alpha), located on the long arm of chromosome 9 on position 9q34.3 [15] , belongs to the nuclear receptor family. These ligand activated receptors differentially regulate gene expression through their ability to recognize specific hormoneresponsive DNA elements (NREs) in the promoter sequence of target genes through the DNA binding domain (DBD) or C domain [16] . RXR alpha regulates at least two separate sets of genes: genes responsible for morphogenesis (cell proliferation, differentiation, and apoptosis), and genes controlling energy status [17] . Thyroid (TR), retinoid (RAR), vitamin D (VDR) receptors and peroxisome proliferator receptor (PPAR), liver X receptor (LXR) and hepatocyte nuclear factor (HNF) as well as most orphan receptors, bind to DNA as heterodimers with RXR [18, 19] . The activation of several permissive heterodimers underlies in RXRs pleiotropic functions, affecting numerous receptor signaling pathways. Dysregulation of these homeostatic control pathways can result in common metabolic disorders such as obesity, type 2 diabetes, and hyperlipidemia, which are often associated with the development of atherosclerosis [20] . Furthermore, data from studies on RXR mutants suggest the function of RXR alpha in myocardial development, growth and differentiation of myocytes [21] .
We focused on an analysis of RXR alpha gene polymorphism in relation to the ABO blood group system (which is encoded by glycosyltransferase gene located at the same region in chromosome 9), in population of chronic heart failure patients. We concentrated on the A blood group carriers because of supposed higher prevalence of cardiovascular diseases within these subjects.
Experimental Procedures

The patient population
A total of 238 patients (172 males and 66 females; age: median value 58, with range 21 to 90 years) with chronic heart failure (CHF) were compared with a group of 246 age-and sex-based control subjects (181 males and 85 females; age: median value 56, with range 27 to 85 years) with no symptoms or clinical signs of cardiovascular diseases. Patients with CHF as a result of ischemic heart disease and idiopathic dilated cardiomyopathy were evaluated at the I Department of Internal Medicine and the II Department of Internal Medicine, Masaryk University in Brno, Czech Republic. The proportion of ischemic heart disease to cardiomyopathy was 3:2. Patients were classified into functional classes NYHA II-IV. All subjects had left ventricular ejection fraction <40% (median 25.0; 5 th and 95 th percentile 15.0; 40.0) and cardio-thoracic index >50%.
Patients were in stable clinical condition and were receiving standard therapy for CHF. Basic characteristics of patients are presented in Table 1 .
In accordance with the ethical standards of the Helsinki Declaration a written informed consent, approved by the Ethics Committee of the Masaryk University in Brno, was obtained from all subjects of the study.
Genetic analysis
Genomic DNA was extracted from peripheral leukocytes using standard proteinase K technique. ABO blood groups -glycosyltranseferase genotypes were detected as in Herrin (1996) . Restriction of PCR products was performed with 3 unites of each restriction enzyme, AluI and KpnI (MBI Ferments, USA), for 1 hour at 37°C. Digested products were loaded onto 3% agarose gel, stained by ethidium bromide and visualised by UV light. The ABO blood group genotypes were identified as AA, AO, AB, BB, BO and OO ( Figure 1 ).
Number of patients 238
Males 172
Females 66
Age (median, range) 58, 21 to 90
Ejection fraction (median, range) 25, 15 to 40
Concomitant diseases
Hypertension 61%
After stroke 4%
Angina pectoris 28%
After myocardial infarction 54%
Diabetes mellitus I type 1%
Diabetes mellitus II type 34%
Basic medication
ACE-I 92%
Angiotensin II receptor blockers 8%
Beta blockers 67%
Diuretics 87%
Aspirin 57%
Calcium channel blockers 5% Spironolacton 63%
Digoxin 65%
Insulin 6%
Oral antidiabetics 20%
Anticoagulation 21%
Nitrates 41%
Allopurinol 23% Table 1 . Basic characteristic of study population.
RXRA A(39526)AA polymorphism was identified by a heteroduplex analysis of 183 bp product and subsequent direct sequencing of positive samples (Genomyx LR). RXRA primers used: forward 5´-GCC TCC TCC TGG CTG TAC TT-3´ and reverse 5´-CTC ATG ACA ACT GCC TTG CT-3´. DNA amplification was performed in a 25 μl volume containing 50 ng genomic DNA with 1 Unit Taq polymerase (MBI Ferments, USA). Samples were denatured in thermocycler (PerkinElmer 9600) at 95°C for 5 min followed by 30 cycles of 95°C for 1 min, 56°C for 1 min and 72°C for 40 s, with a final extension at 72°C for 7 min. Variants of A(39526)AA polymorphism were detected by RFLP analysis using restriction enzyme EcoO109I (MBI Ferments, USA). Digested PCR products (183 bp) were run on 2% agarose gel ( Figure 2 ). RXR alleles were marked as AA -insertion of A at 39526 (159 + 24 bp), A -without insertion (183 bp).
Western Blot Analysis
Proteins were separated on SDS-PAGE, transferred to polyvinylidene fluoride transfer membrane. Non-specific proteins were blocked by incubation in 5% (wt/vol) skim milk in phosphate-buffered saline (PBS; Invitrogen) with 0.1% Tween-20 in PBS (PBS-T) for 1 h at room temperature. After rinsing twice with PBS-T the membranes were incubated overnight at 4°C in PBS-T containing primary anti-RXR antibody (Santa Cruz Biotech., Santa Cruz, CA, USA). After the membranes had been re-washed twice, they were incubated in PBST with secondary antirabbit at room temperature for 1 h. Positive bands were detected using enhanced chemoluminescense (ECL) and western blotting detection reagents (Amersham, Buckinghamshire, UK). Protein band intensities were then quantified using image analyzer.
Statistic analysis
Within all groups the differences in genotype distributions and consistency of genotype frequencies with the Hardy-Weinberg equilibrium were tested using c 2 test on a contingency table of observed versus predicted genotype frequencies. The differences in allelic frequencies were calculated by Fisher's exact test.
Odds ratio (OR) and 95% confidence interval were calculated to estimate the risks related to RXRA polymorphism and ABO blood group genotype. To 
Results
Within chronic heart failure patients the distribution of RXRA [A(39526)AA] polymorphism was consistent with the Hardy-Weinberg equilibrium (P=0.88). However, the distribution of RXRA [A(39526)AA] polymorphism was out of Hardy-Weinberg equilibrium among the control subjects (P=0.0002).
The allele frequencies of RXRA [A(39526)AA] polymorphisms were significantly different between patients with chronic heart failure and the controls (P a =0.02, Table 2 ). Also the AA/AA genotype frequency was lower in the group of patients with CHF compared to the AA/A and A/A genotypes (P=0.01).
In next step, groups of CHF patients and controls were divided according to ABO blood group phenotype and distributions of RXRA A(39526)AA polymorphism were again compared. The differences between CHF patients and controls were highly significant (Table 3) . Significantly lower prevalence of AA allele of this polymorphism within CHF patients with A blood group was detected comparing to controls (P=0.0001). The odds ratio for AA allele in CHF patients with A blood group was 0.24 (95% CI 0.10-0.54; P corr =0.0001) with a power of 96% by α=5%.
For A blood carriers (as in healthy as well in CHF subjects), the allelic frequencies of RXRA gene polymorphism between CHF patients and controls differed significantly (P a =0.0001). Significantly lower prevalence of genotypes with at least one AA allele (AA/A and AA/AA) was detected in CHF A blood carriers compared to the controls (P=0.0008).
Within the CHF group, genotype distributions and allelic frequencies of RXR A(39526)AA polymorphism were compared between A blood group carriers and carriers of blood groups AB, O and B. Significant differences were observed in genotype distributions (P g =0.03) and in allelic frequencies (P a =0.008; A blood group CHF patients: AA=4% and non-A blood 
Discussion
In our study, we observed a strong significant association of A(39526)AA RXR alpha polymorphism and ABO blood group system with chronic heart failure in the Caucasian Czech population. Our data show differences in distributions of A(39526) AA polymorphism between A blood group carriers within CHF patients and controls, where much lower prevalence of RXR alpha AA allele polymorphism was observed. A significant difference was also observed between A blood group and blood groups B, AB and 0 carriers within CHF patients. Previously, in the Czech population the polymorphism RXRA was associated to plaque psoriasis with a positive family history of psoriasis [22] .
No papers on ABO blood groups and RXR alpha polymorphism in association with heart failure were published up to date, but many studies on blood group systems in relation to the cardiovascular diseases can be found [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . All studied cardiovascular disorders were correlated with higher blood group A predominance; that was also published for Czech population [23] .
The eccentric position of A blood group, particularly A1, was noted in relation to higher hypertension rates after five years of follow-up [7] . Neumann [24] reported higher cortisol and TxPA (VLDL toxicity-preventing activity) levels, and quicker stress recovery rates in carriers of blood group A compared to blood group 0 in association to mental stress with cardiovascular risk.
According to another paper by Medalie et al. [5] , subjects with blood groups A1 and A1B tended to have higher incidence rates of myocardial infarction than those with other blood groups, which was also noted in subjects carrying A1 and B for angina pectoris. The functional impact of AB0 blood groups in cardiovascular diseases was clearly suggested in a report by Tarjan et al. [25] that correlated blood group A and angiographically documented coronary atherosclerosis. Carpeggiani et al. [26] suggested an association of non-0 blood group with an increased risk for mortality in ischemic heart disease patients and elevated serum cholesterol in a group with blood group A. Serum cholesterol levels in our group of CHF patients were not elevated, and across the AB0 blood groups it was similar, probably due to the medication regime for chronic heart failure.
Retinoid receptors (RAR alpha, beta; RXR alpha, beta and gamma) are expressed in developing and postnatal heart [27] . RXR alpha activates transcription of genes coding for medium chain acyl-CoA dehydrogenase, [28, 29] and muscle type carnitin-palmytoil transferase I [30] . These two enzymes take part in the fatty acid mitochondrial oxidation, the energy transport pathway in postnatal heart. The culture and in vivo studies demonstrated that stimulation of expression of these genes is partially controlled by heterodimer RXR alpha/PPAR alpha [31] . On the other hand, genes of myosin heavy chain alpha and beta are regulated by heterodimer RXR alpha/TR [32] . PPAR/RXR heterodimers as well as other nuclear hormone receptors are discussed as potential targets for pharmacological intervention in cardiovascular and metabolic diseases [33] [34] [35] . Moreover, data from studies on RXR mutants shows that adult transgenic mice develop a dilated cardiomyopathy, associated with myofibrillar abnormalities and specific deficiencies in respiratory chain complex I and II [21] . Some of the defects in mutant mice are phenocopies of human congenital heart defects [36] and RXR alpha -/-embryos display complex defects, including ventricular septal, atrioventricular cushion, conotruncal ridge defects, with double outlet right ventricle, aorticopulmonary window, and Table 4 . RXR A(39526)AA polymorphism, A blood group CHF patients versus other ABO blood group CHF patients.
P g = P value of genotype distribution differences P a = P value of allelic distribution differences persistent truncus arteriosus. These results suggest that RXR alpha and/or molecules downstream in its signaling pathway may represent congenital heart diseasesusceptibility genes [36] . Moreover, the RA-mediated signaling has an important role in preventing the development of cardiac remodeling [37] . Recently, Choudhary et al. [38] reported that stretch-and Ang II-induced apoptosis was inhibited by RA. This antiapoptotic effects of RA, involves receptor-dependent mechanisms -the RXR and RAR receptors.
Recently, potential functional aspect of A(39526)AA RXR alpha polymorphism was examined using the RXR alpha serum levels. No differences in so defined groups were found. However, this finding of similar RXRA levels for all genotypes does not mean that this polymorphism have no functional impact. Potentially, it could influence the processes that involve binding of DNA, splicing, mRNA stability, and tertiary structure of the protein. In fact, the ligand activated receptors differentially regulate gene expression through their ability to recognize specific hormone-responsive DNA elements in the promoter sequence of target genes through the DNA binding domain, and the polymorphism in RXR alpha is located in the introne between two exons that compose the DNA binding domain, the functional impact could be expected in this way. Moreover, the difference in DBD domain of nuclear receptor suggests functional changes in dimerization [39] . Since RXR as nuclear receptor plays a pivotal role inside the NR superfamily as a ubiquitous heterodimer partner for class II NRs [40] , is only one from target genes including ligands that influence the functional impact.
Our study had adequate statistical power to suggest an association between blood groups and CHF. Nevertheless, the role of polymorphism A(39526)AA in retinoid X receptor gene in relation to ABO blood group system, particularly to A blood group, in cardiovascular disorders should be further explored.
The HW disequilibrium in the control group and equilibrium in the patient group may arise due to selection of individuals, and could be a limitation of this study. The conservative approach is that only SNPs in (nominal) HWE are analyzed. Enrolment of controls without cardiovascular disorder in the age distribution as in CHF patients is itself very strong selection of studied population, and excluding of this polymorphism may lead to potential loss of one of the factors influencing the onset of heart failure, mainly in connection with the ABO blood groups. The last but not least speculative factor could be the evolution of regulation and/or adaptation to food intake changes. RXR is an ancient gene that was subjected to several functional shifts during evolution [39, 41] , and also during embryological development [21, 36] . Detailed studies in this field are needed.
In conclusion, we present significant association of introne single-nucleotide insertion polymorphism of RXRA gene to A blood group in chronic heart failure. These results show an important role for ABO blood group system in cardiovascular disorders, and suggest its close relation to genetic background of chronic heart failure. We suggest that the AA allele of A(39526)AA polymorphism in retinoid X receptor gene could be considered a protective marker for CHF patients with A blood group compared to the CHF subjects with other blood groups.
